Cvs Health (CVS) Common Equity (2009 - 2026)

Cvs Health's Common Equity history runs 18 years deep, the most recent figure standing at $77.6 billion for Q1 2026.

• Quarterly Common Equity rose 0.68% year-over-year to $77.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $77.6 billion (up 0.68% YoY) and the FY2025 annual result came in at $75.2 billion, down 0.68% from the prior year.
• Common Equity was $77.6 billion for Q1 2026 at Cvs Health, up from $75.2 billion in the prior quarter.
• Across five years, Common Equity topped out at $77.6 billion in Q1 2026 and bottomed at $71.5 billion in Q3 2022.
• A 5-year average of $74.7 billion and a median of $75.1 billion in 2024 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity decreased 4.2% — and 2023, when it climbed 6.78%.
• Cvs Health's Common Equity stood at $71.8 billion in 2022, then grew by 6.78% to $76.6 billion in 2023, then slipped by 1.18% to $75.7 billion in 2024, then slipped by 0.68% to $75.2 billion in 2025, then gained by 3.22% to $77.6 billion in 2026.
• Business Quant data shows CVS's Common Equity at $77.6 billion in Q1 2026, $75.2 billion in Q4 2025, and $73.1 billion in Q3 2025.